Literature DB >> 2745687

Susceptibility of methicillin-resistant Staphylococcus aureus to lysostaphin.

M M Huber1, T W Huber.   

Abstract

One hundred and eleven isolates of methicillin-resistant Staphylococcus aureus recovered from patients at the Olin E. Teague Veterans Center from March 1983 to April 1987 were as susceptible to lysis by lysostaphin as methicillin-susceptible S. aureus controls were.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2745687      PMCID： PMC267499          DOI： 10.1128/jcm.27.5.1122-1124.1989

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  13 in total

1.  A simple test system for the separation of staphylococci from micrococci.

Authors:  K H Schleifer; W E Kloos
Journal:  J Clin Microbiol       Date:  1975-03       Impact factor: 5.948

2.  LYSOSTAPHIN: A NEW BACTERIOLYTIC AGENT FOR THE STAPHYLOCOCCUS.

Authors:  C A SCHINDLER; V T SCHUHARDT
Journal:  Proc Natl Acad Sci U S A       Date:  1964-03       Impact factor: 11.205

3.  Studies on lysostaphin. Separation and characterization of three enzymes.

Authors:  O J Iversen; A Grov
Journal:  Eur J Biochem       Date:  1973-10-05

4.  Altered cell walls of Staphylococcus aureus resistant to methicillin.

Authors:  L D Sabath; C D Leaf; D A Gerstein; M Finland
Journal:  Nature       Date:  1970-03-14       Impact factor: 49.962

5.  Lysostaphin disk test for routine presumptive identification of staphylococci.

Authors:  B Poutrel; J P Caffin
Journal:  J Clin Microbiol       Date:  1981-06       Impact factor: 5.948

6.  Lytic action of lysostaphin on susceptible and resistant strains of Staphylococcus aureus.

Authors:  W A Zygmunt; H P Browder; P A Tavormina
Journal:  Can J Microbiol       Date:  1967-07       Impact factor: 2.419

7.  Growth inhibition of unusual strains of Staphylococcus aureus by lysostaphin and other antistaphylococcal antibiotics.

Authors:  W A Zygmunt; H P Browder; P A Tavormina
Journal:  Can J Microbiol       Date:  1966-04       Impact factor: 2.419

8.  Systemic lysostaphin in man--apparent antimicrobial activity in a neutropenic patient.

Authors:  F R Stark; C Thornsvard; E P Flannery; M S Artenstein
Journal:  N Engl J Med       Date:  1974-08-01       Impact factor: 91.245

9.  High-level potentiation of lysostaphin anti-staphylococcal activity by lysozyme.

Authors:  G Cisani; P E Varaldo; G Grazi; O Soro
Journal:  Antimicrob Agents Chemother       Date:  1982-04       Impact factor: 5.191

10.  Reevaluation of the ability of the standardized disk diffusion test to detect methicillin-resistant strains of Staphylococcus aureus.

Authors:  J M Boyce
Journal:  J Clin Microbiol       Date:  1984-06       Impact factor: 5.948
View more
  6 in total

1.  Expression of the lysostaphin gene of Staphylococcus simulans in a eukaryotic system.

Authors:  C M Williamson; A J Bramley; A J Lax
Journal:  Appl Environ Microbiol       Date:  1994-03       Impact factor: 4.792

2.  Lysostaphin disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on artificial surfaces.

Authors:  Julie A Wu; Caroline Kusuma; James J Mond; John F Kokai-Kun
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191

Review 3.  Lysostaphin: A Staphylococcal Bacteriolysin with Potential Clinical Applications.

Authors:  Maria do Carmo de Freire Bastos; Bruna Gonçalves Coutinho; Marcus Lívio Varella Coelho
Journal:  Pharmaceuticals (Basel)       Date:  2010-04-19

Review 4.  Sharpening Host Defenses during Infection: Proteases Cut to the Chase.

Authors:  Natalie C Marshall; B Brett Finlay; Christopher M Overall
Journal:  Mol Cell Proteomics       Date:  2017-02-08       Impact factor: 5.911

5.  Genome-Wide Analysis of Staphylococcus aureus Sequence Type 72 Isolates Provides Insights Into Resistance Against Antimicrobial Agents and Virulence Potential.

Authors:  Nayab Batool; Amen Shamim; Akhilesh Kumar Chaurasia; Kyeong Kyu Kim
Journal:  Front Microbiol       Date:  2021-01-20       Impact factor: 5.640

Review 6.  Staphylococcal-Produced Bacteriocins and Antimicrobial Peptides: Their Potential as Alternative Treatments for Staphylococcus aureus Infections.

Authors:  Logan L Newstead; Katarina Varjonen; Tim Nuttall; Gavin K Paterson
Journal:  Antibiotics (Basel)       Date:  2020-01-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.